Recruiting

Observational Study

Sponsor:

Massachusetts General Hospital

Code:

NCT01527331

Conditions

Advanced Cancer

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

video decision aid

Study Details

Brief summary:

The purpose of this study is to compare the decision making of hospitalized subjects with advanced cancer having a verbal discussion about CPR compared to subjects using a video.

Conditions

Advanced Cancer

Study ID

NCT01527331

Start date

Jun, 2011

Status verified date

Nov, 2020

Primary completion date

Dec, 2012

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Potential subjects will be identified by the research assistant. The specific eligibility criteria include:

1. Over the age of 60
2. The ability to provide informed consent
3. The ability to communicate in English
4. An established diagnosis of metastatic cancer with a prognosis of one year or less confirmed with the attending physician on service.

Study Design

Enrollment

150 participants

Anticipated

Allocation

Randomized

Intervention Model

Single group

Primary purpose

Health Services Research

Interventions and Outcome Measures

Arms

no intervention: control group

usual care

experimental: Video decision aid arm

Interventions

video decision aid

cpr video decision aid

Primary outcome measure

  • preferences for medical care regarding CPR (yes, no or unsure) [ Time Frame: within 5 minutes of surveyor asking the questions ]

Central Contacts and Locations

Central contacts

Angelo Volandes, MD

6176434266avolandes@partners.org

Locations

Massachusetts General Hospital

Recruiting

Boston, Massachusetts, United States, 02115

Contacts

Angelo Volandes, MD

617-643-4266avolandes@partners.org

More Information

Sponsor

Massachusetts General Hospital

Last update posted

Nov 17, 2020

Last verified

Nov, 2020

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2020-11-17.